ArticleAdvanced biomedical research2025
Treatment-resistant Inflammatory Demyelinating Pseudotumor with Marburg-Like Features: A Rare Case Report.
Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory demyelinating pseudotumors (IDPs), also known as tumor-like demyelinating lesions, are rare conditions that mimic intracranial neoplasms, presenting significant diagnostic challenges. The Marburg variant of multiple sclerosis (MS), an aggressive form of demyelinating disease, can present with IDP, further complicating diagnosis. We report the case of a 51-year-old male who developed progressive neurological deficits over one month. Brain MRI revealed bilateral supra- and infratentorial lesions, initially raising suspicion of both demyelinating disease and neoplastic processes. Extensive investigations, including spinal MRI, cerebrospinal fluid (CSF) analysis, and stereotactic biopsy, confirmed a diagnosis of IDP with Marburg-like features. Although initial improvement was achieved by high-dose corticosteroids and plasma exchange, the patient was worsened. The patient was a candidate for high-dose cyclophosphamide. This case underscores the importance of distinguishing IDP from aggressive demyelinating diseases such as Marburg MS, emphasizing the role of biopsy for definitive diagnosis and the critical need for prompt aggressive immunosuppressive therapy. Ultimately, the patient did not consent to initiating the cyclophosphamide pulse and left the hospital against medical advice. Unfortunately, the patient passed away approximately one month later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.